EMA says benefits outweigh risks but also that it is continuing to study possible link with very rare blood clotting disorder
The AstraZeneca coronavirus vaccine is “safe and effective” and its benefits outweigh the risks, Europe’s medicines regulator has said, but it would continue to study possible links between the shot and a very rare blood clotting disorder.
The director of the European Medicines Agency (EMA), Emer Cooke, said the agency’s safety committee had reached “a clear scientific conclusion” and had not found that the vaccine was associated with an increase in the overall risk of blood clots.
